Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Am J Clin Pathol ; 151(3): 324-327, 2019 02 04.
Article in English | MEDLINE | ID: mdl-30383211

ABSTRACT

Objectives: WBC differentials performed using flow cytometry with monoclonal antibodies have been developed in the last decade and are nowadays integrated into the routine workflow of some laboratories. Definition of reference values for each population is required in order to achieve an automatic validation of the results by laboratory software. Methods: We analyzed 584 samples from three hospitals using the Hematoflow solution to define the reference values. Results: Reference values are presented for five groups according to age (0-5, 6-11, 12-19, 20-69, and >69 years). Conclusions: These normal values will be helpful in the definition of relevant threshold for the automatic validation of samples analyzed by flow cytometry and the flagging of pathologic samples.


Subject(s)
Flow Cytometry/methods , Software , Workflow , Adolescent , Adult , Aged , Child , Child, Preschool , Humans , Infant , Leukocyte Count/methods , Middle Aged , Reference Values , Young Adult
3.
Hematol Oncol Clin North Am ; 32(5): 753-763, 2018 10.
Article in English | MEDLINE | ID: mdl-30190015

ABSTRACT

Waldenström macroglobulinemia is a rare indolent B-cell lymphoma. Whole-exome sequencing studies have improved our knowledge of the Waldenström macroglobulinemia mutational landscape. The MYD88 L265P mutation is present in nearly 90% of patients with Waldenström macroglobulinemia. CXCR4 mutations are identified in approximately 30% of MYD88L265P cases and have been associated with ibrutinib resistance in clinical trials. Mutations in CD79B, ARID1a, or TP53 were described at lower frequency. Deciphering the earliest initiating lesions and identifying the molecular alterations leading to disease progression currently represent important goals in the future to identify the most relevant targets for precision therapy in Waldenström macroglobulinemia.


Subject(s)
Drug Resistance, Neoplasm/genetics , Mutation , Neoplasm Proteins , Receptors, CXCR4 , Signal Transduction/genetics , Waldenstrom Macroglobulinemia , Adenine/analogs & derivatives , Humans , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Piperidines , Pyrazoles/therapeutic use , Pyrimidines/therapeutic use , Receptors, CXCR4/genetics , Receptors, CXCR4/metabolism , Waldenstrom Macroglobulinemia/drug therapy , Waldenstrom Macroglobulinemia/genetics , Waldenstrom Macroglobulinemia/metabolism , Waldenstrom Macroglobulinemia/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...